Klick

Medical Affairs is under increasing pressure to demonstrate strategic value—without sacrificing rigor or credibility. Join Robert Groebel III, SVP, Strategic Stakeholder Engagement at Klick Health, at The Digital Strategy & Innovation for Medical Affairs Summit, as he explores how AI-powered decision intelligence can help make that value visible. See more info here: https://lnkd.in/eHz5ySWU

Catch up on the digital health news shaping the week ahead in the Klick Wire: https://bit.ly/4qRGTbu

What happens when pharma rethinks how patients access their medications? In the latest installment of his Difference-Making Strategy series, Brian Kaiser sits down with Chris Millsom to explore how direct-to-patient distribution models are changing the way patients access their drugs. From manufacturer-led programs to aggregated patient ecosystems, they discuss why direct-to-patient is a strategic and operational reset that touches pricing, access, experience design, and the role of AI across the patient journey. Read the conversation now: https://bit.ly/3Zp60q8

Klick has been named one of Canada’s Top 100 Employers for Young People. 👏 This means a lot to us. We’re proud to support early-career talent with meaningful work, mentorship, and room to grow—and even prouder of the people who make our culture what it is 💛 More details on this recognition here 👉 https://lnkd.in/ds4Mpk9

Patients may soon access medication the same way they buy everything else: quickly and directly from their devices. Our latest perspective explores how these forces are reshaping go-to-market strategies, redefining patient engagement, and introducing new risks and opportunities for brands. Learn what this direct-to-patient shift means for patients, providers, and marketers, and how brands can adapt access strategies, messaging, and fulfillment models Read the perspective now: https://bit.ly/45WCWdb

Your weekly snapshot of the digital health stories that matter—now live in the Klick Wire. Read it here: https://bit.ly/45R9hSJ

Big news worth celebrating 🎉  Klick Health has been named the #1 most-awarded health agency and #1 Global Agency in the newly released Creative Rounds Global Health Rankings. Some of the work recognized this year includes: 🏆 Voice 2 Diabetes — Top 10 Pharma Campaigns (#8) 🏆 Love Captured — Top 10 Health Campaigns of the Year (#2) and Not-for-Profit of the Year 🏆 The Trial — Top 10 Health Campaigns of the Year (#5) 🌟 Bernardo Romero and Rich Levy — Named among the Most Influential Creatives of the Year These honors are a reflection of the incredible teams and partners behind work rooted in creativity, science, and a shared commitment to improving health outcomes. Read more here: https://bit.ly/3LDD8Y2

Expanding access to medication—safely and appropriately—is a powerful idea. As highlighted in today’s White House discussion, removing unnecessary barriers could create real efficiencies for both patients and the healthcare system. With the FDA’s new ACNU NDA pathway now live, important questions arise: 👉 Should access be enabled via ACNU, using labeling plus an additional condition (e.g., technology-enabled triage)? 👉 Should access be OTC, relying on labeling alone to guide appropriate use? 👉 Which therapies or use cases are best suited for expanded access (acute vs. chronic, initiation vs. refills, new vs. stable patients)? How should insurers approach coverage for ACNU and OTC access models There’s an opportunity to expand self-directed care while ensuring patients can engage providers when needed—an approach that’s good for healthcare and business. To continue the conversation, reach out to Paul Wardle at Klick. https://lnkd.in/eHzeukQm

We are proud to share that Paul Wardle and Aleksandra Lyons have a new article published in the Journal of Regulatory Affairs exploring a novel FDA regulatory pathway designed to expand direct-to-consumer access to medications. A timely look at how technology, regulation, and consumer-centric design can work together to remove barriers to care. Read it here: https://lnkd.in/ehC-_meC

I am thrilled to share that I will be serving on ADC 105th Annual awards Pharma & Health/Wellness Jury! It's an honor to be selected amongst the best creative directors in our field and reunite with friends old and new, including our esteemed Jury President Laura Florence, and the super talented Julianna Strong, Franklin Williams, Daniela Varela, Guy Mannshardt Bricio, Roger Stephens, Sharon Howard-Butler, Severine Autret, Gunther Brodhecker, André Pedroso, and Vanessa Queiroz. As the oldest creative industry organization, the ACD has sponsored the longest continually running award show (honoring advertising, design, craftsmanship, motion, illustration, and photography) and forwards all proceeds to programs that help develop the future of our industry. Submit your work at adcawards.org and help us continue to push the industry forward! The final deadline is Friday, February 20. #ADCAWARDS Klick | The One Club for Creativity